Publications
Featured Publications from the Scientific Literature
- Nagashima,, K., et al.Genetic and pharmacological inhibition of PDK1 in cancer cells characterization of a selective allosteric kinase inhibitorJ. Biol. Chem 286:6433 (2011)
- Sneeringer, C.J., et al.Coordinated activities of wild-type plus mutant EZH2 drive tumor-associated hypertrimethylation of lysine 27 on histone H3 (H3K27) in human B-cell lymphomasPNAS 107:20980 (2010)
- Cittelly, D. M., et al.Oncogenic HER2D16 suppresses miR-15a/16 and deregulates BCL-2 to promote endocrine resistance of breast tumorsCarcinogenesis 31:2049 (2010)
- Pan, Y. et al.Sprouty2-modulated Kras signaling rescues Shp2 deficiency during lens and lacrimal glad development.Development 137, 1085-1093 (2010)
- Markovic, D et al.Intracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades.Mol Endocrinol.22(3): 689-706 (2008)
- Ramsay, AJ et al.Kallikrein-related peptidase 4 (KLK4) initiates intracellular signaling via protease-activated receptors (PARs). KLK4 and PAR-2 are co-expressed during prostate cancer progressionJ Biol Chem. 283(18): 12293-304 (2008)
- Wang, YV et al.Quantitative analyses reveal the importance of regulated Hdmx degradation for p53 activation.Proc Natl Acad Sci USA. 104(30): 12365-70 (2007)
- Wishart, TM et al.Differential proteomics analysis of synaptic proteins identifies potential cellular targets and protein mediators of synaptic neuroprotection conferred by the slow Wallerian degeneration (Wlds) gene.Mol Cell Proteomics. 6(8): 1318-30 (2007)
Publication Lists
- ODYSSEY® PublicationsJanuary - March 2012
- ODYSSEY® PublicationsOctober - December 2011
- ODYSSEY® Publications:
In-Cell Western™Winter 2012 - ODYSSEY® Publications:RNAi Interference Vol 2 Jul 2009 - Dec 2011
- Publishing data from your LI-COR system?




